SG10201912650QA - Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them - Google Patents
Nanoliposomes comprising corticosteroid as medicaments and methods to prepare themInfo
- Publication number
- SG10201912650QA SG10201912650QA SG10201912650QA SG10201912650QA SG10201912650QA SG 10201912650Q A SG10201912650Q A SG 10201912650QA SG 10201912650Q A SG10201912650Q A SG 10201912650QA SG 10201912650Q A SG10201912650Q A SG 10201912650QA SG 10201912650Q A SG10201912650Q A SG 10201912650QA
- Authority
- SG
- Singapore
- Prior art keywords
- nanoliposomes
- corticosteroid
- medicaments
- prepare
- methods
- Prior art date
Links
- 239000003246 corticosteroid Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201510370T | 2015-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201912650QA true SG10201912650QA (en) | 2020-02-27 |
Family
ID=59057346
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201912650QA SG10201912650QA (en) | 2015-12-17 | 2016-11-28 | Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them |
| SG11201805101RA SG11201805101RA (en) | 2015-12-17 | 2016-11-28 | Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201805101RA SG11201805101RA (en) | 2015-12-17 | 2016-11-28 | Nanoliposomes comprising corticosteroid as medicaments and methods to prepare them |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20180360758A1 (en) |
| CN (1) | CN108430457A (en) |
| SG (2) | SG10201912650QA (en) |
| WO (1) | WO2017105344A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201900008745A1 (en) * | 2019-06-12 | 2020-12-12 | Univ Degli Studi Genova | ENGINEERED NANO-LIPOSOMES FOR A TARGETED THERAPY OF ATHEROSCLEROSIS AND THEIR PREPARATION PROCEDURE |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060115523A1 (en) * | 2004-12-01 | 2006-06-01 | Konduri Kameswari S | Sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal |
| JP5355890B2 (en) * | 2004-09-09 | 2013-11-27 | イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム | Liposomal composition of glucocorticoids and glucocorticoid derivatives |
| SI1919450T1 (en) * | 2005-09-01 | 2014-10-30 | Meda Ab | Antihistamine- and corticosteroid-containing liposome composition and its use for the manufacture of a medicament for treating rhinitis and related disorders |
| EP2127639A1 (en) * | 2008-05-26 | 2009-12-02 | Universiteit Utrecht Holding B.V. | Corticosteroid containing liposomes for treatment of cardiovascular diseases |
| CA2800693A1 (en) * | 2010-05-28 | 2011-12-01 | Purdue Research Foundation | Delivery of therapeutic agents to inflamed tissues using folate-targeted agents |
| DK2773325T3 (en) * | 2011-11-04 | 2019-01-14 | Enceladus Pharmaceuticals B V | LIPOSOMAL CORTICOSTEROIDS FOR TREATMENT OF INFLAMMATORY DISORDERS BY HUMANS |
| US9393320B2 (en) * | 2011-12-07 | 2016-07-19 | Universidade Do Minho | Liposomes and its production method |
| CN104173285A (en) * | 2013-05-23 | 2014-12-03 | 上海市第七人民医院 | Preparation method for triamcinolone acetonide acetate ultradeformable nanometer lipid vesicle spraying agent and application to target hypertrophic scars |
-
2016
- 2016-11-28 SG SG10201912650QA patent/SG10201912650QA/en unknown
- 2016-11-28 CN CN201680074636.8A patent/CN108430457A/en active Pending
- 2016-11-28 SG SG11201805101RA patent/SG11201805101RA/en unknown
- 2016-11-28 WO PCT/SG2016/050584 patent/WO2017105344A1/en not_active Ceased
- 2016-11-28 US US16/063,062 patent/US20180360758A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201805101RA (en) | 2018-07-30 |
| US20180360758A1 (en) | 2018-12-20 |
| CN108430457A (en) | 2018-08-21 |
| WO2017105344A1 (en) | 2017-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258931A (en) | Therapeutic compounds and methods | |
| IL249011A0 (en) | Methods and compositions relating to exosomes | |
| IL250744A0 (en) | Method of producing palbociclib and pharmaceutical compositions comprising the same | |
| PT3442480T (en) | Topical administration method | |
| EP3377406A4 (en) | Detachable pilotable capsules and aircrafts including detachable pilotable capsules | |
| ZA201606704B (en) | Topical corticosteroid compositions | |
| IL257392B (en) | Pyrazolyl-substituted heteroaryls and their use as medicaments | |
| SG11201801856XA (en) | Biaryl derivative and medicine containing same | |
| PL3137473T3 (en) | Pt (iv) derivatives and nanocarriers comprising them | |
| PT3202759T (en) | Alpha-aminoamide derivative compound and pharmaceutical composition comprising same | |
| ZA201703398B (en) | Pharmaceutical composition and methods | |
| EP3201138A4 (en) | Compositions and methods for selective anion removal | |
| SG10201609768QA (en) | Methods And Apparatus To Improve Interprocess Communication | |
| EP3464319A4 (en) | Intermediates and processes to prepare anidulafungin | |
| EP3169316A4 (en) | Compositions and methods for reducing overdose | |
| IL257983A (en) | Enhanced delivery of drugs to the brain | |
| GB201502845D0 (en) | Topical pharmaceutical formulation | |
| GB201406172D0 (en) | Therapy and pharmaceutical composition | |
| ZA201607148B (en) | Pharmaceutical composition including anti-fungal agent and steroid | |
| EP3182968A4 (en) | Capsaicinoids and uses thereof as medicaments | |
| SG11201505661XA (en) | Characterizing tsv microfabrication process and products | |
| EP3397286A4 (en) | Compositions and methods to affect skin irritation | |
| EP3197470A4 (en) | Cis-gnetin h and trans-gnetin h as therapeutic agents | |
| GB201700560D0 (en) | Pharmaceutical composition comprising docetaxel | |
| SG11201702260RA (en) | Anti-cancer agent and cancer cell killing method |